4-(2-amino-ethyl)-thiophenol | 130755-67-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-(2-amino-ethyl)-thiophenol
• 英文别名: β-(4-Mercapto-phenyl)-aethylamin；4-Mercapto-β-phenaethylamin；4-(2-Amino-aethyl)-thiophenol；4-(2-Aminoethyl)benzenethiol
• CAS: 130755-67-8
• 化学式: C₈H₁₁NS
• 分子量: 153.248
• InChiKey: LMQBGUFOFQYPJS-UHFFFAOYSA-N

物化性质

• 熔点：
  216-217 °C(Solv: water (7732-18-5))
• 沸点：
  271.3±15.0 °C(Predicted)
• 密度：
  1.106±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  10
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  27
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  N-[2-(4-硝基苯基)乙基]苯甲酰胺 在 盐酸 、 tin 、 乙醇 作用下， 生成 4-(2-amino-ethyl)-thiophenol
  参考文献：
  名称：

  King, Journal of the Chemical Society, 1915, vol. 107, p. 226

  摘要：

  DOI：

文献信息

• Novel 2-pyridinecarboxamide derivatives
  申请人：Mitsuya Morihiro

  公开号：US20060258701A1

  公开（公告）日：2006-11-16

  The present invention relates to a compound which has a glucokinase-activating effect and is useful as a therapeutic agent for diabetes mellitus, being represented by a formula (I): [wherein X 1 represents a nitrogen atom, sulfur atom, oxygen atom or the like; R 1 represents a 6- to 10-membered aryl group, 5- to 7-membered heteroaryl group or the like; D represents an oxygen atom or sulfur atom; R and R 3 are the same or different, each representing a hydrogen atom, lower alkyl group or the like; a formula (II) represents an optionally substituted 5- to 7-membered heteroaryl group or the like; a formula (III) represents a monocyclic or bicyclic heteroaryl group] or a pharmaceutically acceptable salt thereof.

  本发明涉及一种化合物，具有激活葡萄糖激酶的效果，并可用作糖尿病治疗剂，其化学式表示为（I）：[其中X1表示氮原子、硫原子、氧原子或类似物；R1表示6-至10-成员芳基基团、5-至7-成员杂芳基基团或类似物；D表示氧原子或硫原子；R和R3相同或不同，分别表示氢原子、低碳基或类似物；式（II）表示可选取代的5-至7-成员杂芳基团或类似物；式（III）表示单环或双环杂芳基团]或其药学上可接受的盐。
• Formamide Derivatives For The Treatment of Diseases
  申请人：Brown Alan Daniel

  公开号：US20080207689A1

  公开（公告）日：2008-08-28

  The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.

  本发明涉及式(1)化合物以及制备该化合物的中间体、含有该化合物的组合物的制备方法和用途。根据本发明的化合物在许多疾病、紊乱和状况中具有有用性，特别是在炎症、过敏和呼吸系统疾病、紊乱和状况方面。
• NOVEL 2-PYRIDINECARBOXAMIDE DERIVATIVES
  申请人：MITSUYA MORIHIRO

  公开号：US20100041660A1

  公开（公告）日：2010-02-18

  The present invention relates to a compound which has a glucokinase-activating effect and is useful as a therapeutic agent for diabetes mellitus, being represented by a formula (I): [wherein X 1 represents a nitrogen atom, sulfur atom, oxygen atom or the like; R 1 represents a 6- to 10-membered aryl group, 5- to 7-membered heteroaryl group or the like; D represents an oxygen atom or sulfur atom; R 2 and R 3 are the same or different, each representing a hydrogen atom, lower alkyl group or the like; a formula (II) represents an optionally substituted 5- to 7-membered heteroaryl group or the like; a formula (III) represents a monocyclic or bicyclic heteroaryl group] or a pharmaceutically acceptable salt thereof.

  本发明涉及一种具有葡萄糖激酶激活作用并且可用作糖尿病治疗剂的化合物，其化学式为（I）：[其中X1代表氮原子、硫原子、氧原子或类似物；R1代表6到10个成员的芳基基团、5到7个成员的杂芳基团或类似物；D代表氧原子或硫原子；R2和R3相同或不同，每个代表氢原子、低碳基团或类似物；化学式（II）代表可选取代的5到7个成员的杂芳基团或类似物；化学式（III）代表单环或双环杂芳基团]或其药学上可接受的盐。
• IMPLANTABLE CARDIAC STIMULATION DRUG RELEASING ELECTRODE
  申请人：Norlin Weissenrieder Anna

  公开号：US20120046724A1

  公开（公告）日：2012-02-23

  In an implantable cardiac stimulation electrode, an implantable cardiac stimulation lead, and a stimulation delivery method, the electrode body is provided with a matrix metalloproteinase inhibitor or a precursor thereof, in a release structure that allows release of the metalloproteinase inhibitor or precursor thereof from the electrode body into surrounding tissue, after implantation.
• US7547731B2
  申请人：——

  公开号：US7547731B2

  公开（公告）日：2009-06-16